Navigating New Frontiers in Breast Cancer Care Pathway Intelligence: The Role of Providers and AI

Jay Carlson, D.O., is the Medical Director for the Oncology Service Line for Mercy Health and the Clinical Chair of Mercy Research and. He is also the Principal Investigator for Cancer Research for the Ozarks, an NCI sponsored NCORP.

Molly Porter is a nurse practitioner with Mercy’s Center for Precision Medicine, focusing on early cancer detection, disease prevention, and care coordination across the diagnostic continuum. Molly earned her Bachelor of Science in Nursing from the University of Missouri Columbia and her Master of Science in Nursing from Maryville University.

Dr. Calvin Chao is the Senior Vice President of Medical Affairs at Tempus. Previously, Dr. Chao spent thirteen years leading studies and education for the Oncotype DX Breast, Prostate, and Colon Cancer assays at Genomic Health, later acquired by Exact Sciences. Prior to that role, he worked in various bio-pharmaceutical medical director positions at Onyx Pharmaceuticals, PDL BioPharma, TAP Pharmaceuticals, and SmithKline Beecham. In his early career, Dr. Chao practicedas a board-certified internist and hospitalist at Kaiser Permanente in California for ten years. He earned his MD from the University of Texas Medical Branch, completed his medical residency at Presbyterian-St. Luke’s Medical Center in Denver, Colorado, received his MBA from St. Mary’s College, California, and his BS in Chemical Engineering from University of California, Berkeley.

Dr. Cohen is a leading medical oncologist and cancer researcher who brings a unique combination of extensive clinical and research experience to Tempus’ leadership team. He was most recently the Chief of the Division of Hematology-Oncology as well as the Associate Director of Clinical Science at UC San Diego (UCSD) Moores Cancer Center. Dr. Cohen also led the Precision Immunotherapy Clinic and co-directed the San Diego Center for Precision Immunotherapy at UCSD. Before UCSD, Dr. Cohen spent 15 years at the University of Chicago, where he was the co-director of the Head and Neck Cancer Program as well as Hematology/Oncology Fellowship Program Director.